Before the protocol, every patient underwent a Breast Cancer Risk Assessment Tool evaluation, yet there was no established protocol for sharing the results.

The new study identifies 4,248 CpG sites associated with the risk of seven different types of cancer: breast, colorectal, renal cell, lung, ovarian, prostate and testicular germ cell cancers.

Vanderbilt-Ingram Cancer Center celebrated a ribbon cutting recently  at the Cookeville Regional Medical Center Cancer Center, where Vanderbilt-Ingram medical oncologists, radiation oncologists and advanced practice nurses are now the exclusive providers for cancer care.

There, she will develop and implement program aims, participate in strategic decision-making in the Cancer Center, direct pilot project funding, facilitate interactions among Cancer Center members, and assist in the recruiting activities for the 42-member program with over $11.7 million in annual peer-reviewed funding.

The findings were so promising that the clinical trial is being redesigned to investigate whether radiation treatment can also be avoided.

The authors hope the report will provide insight on the importance of education, screening and awareness to all health care providers.

The Vanderbilt study used RNA-sequencing data generated in multiple normal tissues, along with matched genotype data from the Genotype-Tissue Expression Project as well as large-scale genomic data for cancers of the breast, ovary, prostate, colorectum, lung and pancreas.